Compare PLSE & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | MFA |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 976.0M |
| IPO Year | 2016 | N/A |
| Metric | PLSE | MFA |
|---|---|---|
| Price | $14.08 | $9.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $22.00 | $10.96 |
| AVG Volume (30 Days) | 183.4K | ★ 1.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | $86,000.00 | ★ $279,011,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,002.94 | $14.85 |
| P/E Ratio | ★ N/A | $11.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $7.85 |
| 52 Week High | $25.00 | $11.08 |
| Indicator | PLSE | MFA |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 59.24 |
| Support Level | $13.12 | $9.45 |
| Resistance Level | $14.75 | $9.72 |
| Average True Range (ATR) | 0.64 | 0.15 |
| MACD | 0.23 | 0.01 |
| Stochastic Oscillator | 62.50 | 83.64 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.